PH12012500773A1 - A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof - Google Patents

A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof

Info

Publication number
PH12012500773A1
PH12012500773A1 PH1/2012/500773A PH12012500773A PH12012500773A1 PH 12012500773 A1 PH12012500773 A1 PH 12012500773A1 PH 12012500773 A PH12012500773 A PH 12012500773A PH 12012500773 A1 PH12012500773 A1 PH 12012500773A1
Authority
PH
Philippines
Prior art keywords
sugar
salt
skin external
preventing
external composition
Prior art date
Application number
PH1/2012/500773A
Other languages
English (en)
Inventor
Won Seog Choi
Dong-Yeul Kwon
Original Assignee
Won Seog Choi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44048707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12012500773(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Won Seog Choi filed Critical Won Seog Choi
Publication of PH12012500773A1 publication Critical patent/PH12012500773A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH1/2012/500773A 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof PH12012500773A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20090099333 2009-10-19
KR1020100097774A KR101133723B1 (ko) 2009-10-19 2010-10-07 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
PCT/KR2010/007068 WO2011049327A2 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof

Publications (1)

Publication Number Publication Date
PH12012500773A1 true PH12012500773A1 (en) 2016-10-26

Family

ID=44048707

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/500773A PH12012500773A1 (en) 2009-10-19 2010-10-15 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof

Country Status (14)

Country Link
US (2) US20120201904A1 (enExample)
EP (2) EP2490700A4 (enExample)
JP (2) JP6044831B2 (enExample)
KR (1) KR101133723B1 (enExample)
CN (1) CN102573858B (enExample)
AU (1) AU2010308741B2 (enExample)
BR (1) BR112012008470A2 (enExample)
CA (1) CA2778371C (enExample)
MX (1) MX2012004509A (enExample)
MY (1) MY182983A (enExample)
NZ (1) NZ599265A (enExample)
PH (1) PH12012500773A1 (enExample)
RU (1) RU2536264C2 (enExample)
WO (1) WO2011049327A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433641B2 (en) * 2009-10-19 2016-09-06 Won Seog Choi Skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
JP5547123B2 (ja) * 2011-03-30 2014-07-09 株式会社 資生堂 油中水型乳化化粧料
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
RU2709464C2 (ru) 2015-09-29 2019-12-18 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
KR101771479B1 (ko) 2016-12-23 2017-09-05 유한회사 아이에스티케이3 천연식물추출물 및 당을 유효성분으로 함유하는 질염예방 및 치료용 조성물
US12029748B2 (en) 2017-02-28 2024-07-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
KR102091440B1 (ko) * 2018-07-26 2020-03-20 이기용 질 세정제를 이용한 질 세정용 위생용품
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин
KR102285430B1 (ko) 2020-01-06 2021-08-04 주식회사 벤스랩 염화칼륨을 포함하는 여성세정제 조성물
KR102213286B1 (ko) 2020-07-31 2021-02-05 정소영 질염의 치료 및 자궁경부이형성증의 예방용 한약 조성물
KR20260006643A (ko) * 2023-06-20 2026-01-13 토요 슈가 리파이닝 컴퍼니 리미티드 세균의 증식 억제제, 그것을 포함하는 화장품, 의약 부외품 및 의약 조성물, 그리고 세균의 증식 억제 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823163A (en) * 1956-10-11 1958-02-11 Richard K Thoms Antivaginitis process and cation exchange resin composition
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US5098709A (en) * 1987-07-21 1992-03-24 Kang Kwon J Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
AU675304B2 (en) * 1993-06-04 1997-01-30 Senju Pharmaceutical Co., Ltd. Ophthalmic topical agent
US5916176A (en) * 1994-08-25 1999-06-29 Caillouette; James C. Estrogen or estradiol need determination by vaginal or urethral acidity determination
AU3136897A (en) * 1996-05-22 1997-12-09 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
WO1999026636A1 (fr) * 1997-11-24 1999-06-03 Zhongming Zeng Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
KR20010029068A (ko) * 1999-09-29 2001-04-06 강권중 죽염과 운모를 유효성분으로 함유하는 질정제
RU2234325C1 (ru) * 2003-12-10 2004-08-20 ЗАО "Аэромед" Способ лечения заболеваний влагалища и устройство для его осуществления (варианты)
CN100389763C (zh) * 2004-02-10 2008-05-28 周世兰 改善妇女阴道酸、湿性的乳酸、甘油制剂
SE528337C2 (sv) * 2004-06-23 2006-10-24 Nestor Medical Ab Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
US20080286384A1 (en) * 2004-09-15 2008-11-20 Renee Reichert Topical Wound Care Product Containing Hyssop
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20080193428A1 (en) * 2005-04-27 2008-08-14 Shenzhen Phlora Biotechnology Limited Composition and Method for Modulating and Maintaining Vaginal Bacterial Flora and Vaginal Acidity
CN101442911A (zh) * 2006-01-24 2009-05-27 弗杰尔和弗佐德马特有限公司 用于处理肉的、含有糖和盐的组合物
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
CN101530403A (zh) * 2008-03-14 2009-09-16 郭进军 用于治疗或预防妇女阴道炎、宫颈糜烂的木糖醇组合物
CN101797269B (zh) * 2010-03-23 2012-01-04 杨霞 一种调节女性阴道微生态的生理平衡液

Also Published As

Publication number Publication date
RU2012113101A (ru) 2013-11-27
KR101133723B1 (ko) 2012-04-09
JP6044831B2 (ja) 2016-12-14
EP2490700A2 (en) 2012-08-29
JP2013508269A (ja) 2013-03-07
AU2010308741B2 (en) 2015-02-19
MY182983A (en) 2021-02-05
NZ599265A (en) 2014-03-28
CA2778371A1 (en) 2011-04-28
HK1167348A1 (en) 2012-11-30
CA2778371C (en) 2017-09-05
KR20110043448A (ko) 2011-04-27
JP6429131B2 (ja) 2018-11-28
CN102573858B (zh) 2013-09-18
US20120201904A1 (en) 2012-08-09
RU2536264C2 (ru) 2014-12-20
MX2012004509A (es) 2012-06-04
EP2490700A4 (en) 2013-08-07
JP2017025078A (ja) 2017-02-02
WO2011049327A2 (en) 2011-04-28
CN102573858A (zh) 2012-07-11
US20140037758A1 (en) 2014-02-06
WO2011049327A3 (en) 2011-10-20
BR112012008470A2 (pt) 2016-04-05
EP3192516A1 (en) 2017-07-19
AU2010308741A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
EP2490700A4 (en) EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF
GB2491328A (en) Immediate/delayed drug delivery
PL2210588T3 (pl) Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
GB2491775A (en) Pulsatile drug release
GB2491327A (en) Delayed prolonged drug delivery
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
MX337614B (es) Tratamiento de lupus nefritis usando laquinimod.
MX338554B (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
WO2010132882A8 (en) Sublingual dexmedetomidine compositions and methods of use thereof
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
SG10201501579WA (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
EP2575842A4 (en) COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES
MX2014006662A (es) Direccionamiento de en2, pax2, y/o defb1 para tratamiento de afecciones de la próstata.
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
HK1201189A1 (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
EP2870964A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF COLITIET COMPRISING S-ALLYL-L-CYSTEINE AS ACTIVE INGREDIENT AND MEDICAL PREPARATION COMPRISING THE SAME
UA109944U (uk) Фармацевтична композиція для зниження рівня n-оксиду триметиламіну
WO2013038200A3 (en) Neurodevelopmental disorders
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
WO2011062426A3 (ko) 염료 피부 자극 완화용 조성물
WO2010086736A3 (en) Use of the combination of resveratrol with cysteine and derivatives thereof
MX2007013449A (es) Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo.